Register entryShortage reported
Lifsa Drugs LLC
- Registered sites
- 1
- Drug products
- 9
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Finished drug manufactureRelabellingRepackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Lifsa Drugs LLC | New Brunswick, NJUnited States | Finished drug manufacture, Relabelling, Repackaging | 3016774395 |
Alert
Products in shortage
1| Drug | Presentation | Availability |
|---|---|---|
| Isocarboxazid Tablet | Marplan, Tablet, 10 mg, 100 count bottle (NDC 72336-032-01) | Limited Availability |
Catalogue
Marketed products
9Showing 9 of 9.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Chlorzoxazone | Chlorzoxazone | TABLET | ANDA |
| Diclofenac Potassium | Diclofenac potassium | CAPSULE, LIQUID FILLED | ANDA |
| Glimepiride 3 mg | Glimepiride | TABLET | ANDA |
| MARPLAN | isocarboxazid | TABLET | NDA |
| Metformin Hydrochloride | Metformin Hydrochloride | TABLET | ANDA |
| Metformin Hydrochloride | Metformin Hydrochloride | TABLET | ANDA |
| Ondansetron | Ondansetron | TABLET, ORALLY DISINTEGRATING | ANDA |
| Tolmetin Sodium | Tolmetin Sodium | TABLET | ANDA |
| Valsartan | Valsartan | SOLUTION | ANDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.